Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ASPYRE-Lung: validation of a simple, fast, robust and novel method for multi-variant genomic analysis of actionable NSCLC variants in FFPE tissue.
Evans RT, Gillon-Zhang E, Brown JN, Knudsen KE, King C, Green AS, Silva AL, Mordaka JM, Palmer RN, Tomassini A, Collazos A, Xyrafaki C, Turner I, Ho CH, Nugent D, Jose J, Andreazza S, Potts ND, von Bargen K, Gray ER, Stolarek-Januszkiewicz M, Cooke A, Reddi HV, Balmforth BW, Osborne RJ. Evans RT, et al. Among authors: knudsen ke. Front Oncol. 2024 Sep 25;14:1420162. doi: 10.3389/fonc.2024.1420162. eCollection 2024. Front Oncol. 2024. PMID: 39386190 Free PMC article.
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
Sardar S, McNair CM, Ravindranath L, Chand SN, Yuan W, Bogdan D, Welti J, Sharp A, Ryan NK, Knudsen LA, Schiewer MJ, DeArment EG, Janas T, Su XA, Butler LM, de Bono JS, Frese K, Brooks N, Pegg N, Knudsen KE, Shafi AA. Sardar S, et al. Among authors: knudsen ke. Oncogene. 2024 Sep 13. doi: 10.1038/s41388-024-03148-4. Online ahead of print. Oncogene. 2024. PMID: 39266679
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.
Sardar S, McNair CM, Ravindranath L, Chand SN, Yuan W, Bogdan D, Welti J, Sharp A, Ryan NK, Schiewer MJ, DeArment EG, Janas T, Su XA, Butler LM, de Bono JS, Frese K, Brooks N, Pegg N, Knudsen KE, Shafi AA. Sardar S, et al. Among authors: knudsen ke. bioRxiv [Preprint]. 2024 May 7:2024.05.07.592966. doi: 10.1101/2024.05.07.592966. bioRxiv. 2024. Update in: Oncogene. 2024 Sep 13. doi: 10.1038/s41388-024-03148-4. PMID: 38766099 Free PMC article. Updated. Preprint.
27-hydroxycholesterol and DNA damage repair: implication in prostate cancer.
Galvan GC, Friedrich NA, Das S, Daniels JP, Pollan S, Dambal S, Suzuki R, Sanders SE, You S, Tanaka H, Lee YJ, Yuan W, de Bono JS, Vasilevskaya I, Knudsen KE, Freeman MR, Freedland SJ. Galvan GC, et al. Among authors: knudsen ke. Front Oncol. 2023 Dec 21;13:1251297. doi: 10.3389/fonc.2023.1251297. eCollection 2023. Front Oncol. 2023. PMID: 38188290 Free PMC article.
Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer.
Santasusagna S, Zhu S, Jawalagatti V, Carceles-Cordon M, Ertel A, Garcia-Longarte S, Song WM, Fujiwara N, Li P, Mendizabal I, Petrylak DP, Kelly WK, Reddy EP, Wang L, Schiewer MJ, Lujambio A, Karnes J, Knudsen KE, Cordon-Cardo C, Dong H, Huang H, Carracedo A, Hoshida Y, Rodriguez-Bravo V, Domingo-Domenech J. Santasusagna S, et al. Among authors: knudsen ke. Cancer Discov. 2023 Dec 12;13(12):2584-2609. doi: 10.1158/2159-8290.CD-23-0306. Cancer Discov. 2023. PMID: 37676710 Free PMC article.
263 results